MedTrace Logo

Olive Oil and Cardiovascular Health

NCT01983943 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2015-06-03

No results posted yet for this study

Summary

The purpose of this study is to conduct a double-blind, randomized controlled trial (RCT), to determine if six month supplementation of olive oil can improve the health of the blood vessels and improve long term health of the heart and blood vessels, in patients requiring percutaneous coronary intervention (PCI).

Conditions

Interventions

DIETARY_SUPPLEMENT

Hydroxytyrosol, the active ingredient in olive oil.

A 40mg capsule will be taken once daily for 6 months.

DIETARY_SUPPLEMENT

Placebo

A 40mg placebo will be taken once per day for 6 months.

BEHAVIORAL

Nutrition counseling

Nutrition counseling on eating a healthy diet will be offered once at baseline.

DEVICE

Endopat

An endopat test will be administered twice, once and baseline and once after 6 months of supplementation, to test endothelial function. This is a non-invasive test that takes about 15 minutes.

Sponsors & Collaborators

Principal Investigators

  • Amir Lerman, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01983943 on ClinicalTrials.gov